Curtis Leclerc, MSc, B.Kin

University of British Columbia

Vancouver, BC

Disclosures:

Presentations

Sep 29

211 - Treatment with Stereotactic Ablative Radiotherapy for up to Five Oligometastases in Patients with Cancer: Long-Term Outcomes of the Nonrandomized Phase 2 SABR-5 Clinical Trial

10:45am - 10:55am PT